The fast pace of CRISPR-based clinical research challenges existing regulatory frameworks, requiring adaptive oversight to ensure patient safety and ethical compliance.
The fast pace of CRISPR-based clinical research challenges existing regulatory frameworks, requiring adaptive oversight to ensure patient safety and ethical compliance.
Leave a Reply